Investing in small-cap health care companies can be tricky, with stocks that can soar or crash based on the results of a single clinical trial. However, equities.com's Small-Cap Stars, our proprietary list of small-cap companies with characteristics we've found to be most predictive of future success, isolates those companies that are best positioned to succeed.
Here are today's top performing health care Small-Cap Stars:
Galectin Therapeutics Inc. (GALT)
Galectin Therapeutics Inc. gained 22.71% to $6.16. The gains came on a volume of 1,929,750 shares against an average daily volume of 1,100,203 shares. Galectin Therapeutics Inc. has had a trading range from $19.11 to $4.28 over the last year, it has a 50-day SMA of $10.16, and a 200-day SMA of $11.55.
Galectin Therapeutics, Inc. is a development-stage company engaged in drug research and development to create new therapies for fibrotic disease and cancer.
Cancer Genetics Inc. (CGIX)
Cancer Genetics Inc. gained 7.54% to $9.41. The gains came on a volume of 172,390 shares against an average daily volume of 50,130 shares. Cancer Genetics Inc. has had a trading range from $23.25 to $8.48 over the last year, it has a 50-day SMA of $10.23, and a 200-day SMA of $13.60.
Cancer Genetics, Inc., is an early-stage diagnostics company focused on developing and commercializing proprietary genomic tests and services to improve and personalize the diagnosis, prognosis and response to treatment of cancer.
Erba Diagnostics (ERB)
Erba Diagnostics gained 7.04% to $3.80. The gains came on a volume of 443,620 shares against an average daily volume of 82,218 shares. Erba Diagnostics has had a trading range from $4.13 to $0.77 over the last year, its P/E ratio is 131.5, it has a 50-day SMA of $2.30, and a 200-day SMA of $2.34.
ERBA Diagnostics Inc develop, manufacture and market diagnostic test kits, and instrumentation in the areas of autoimmune, chemistry, hematology, diabetes and infectious diseases.
Neuralstem Inc. (CUR)
Neuralstem Inc. gained 6.61% to $3.87. The gains came on a volume of 1,792,860 shares against an average daily volume of 603,539 shares. Neuralstem Inc. has had a trading range from $4.81 to $1.55 over the last year, it has a 50-day SMA of $3.56, and a 200-day SMA of $3.48.
Neuralstem, Inc. is a biotechnology company. It is engaged in the development and commercialization of treatments for central nervous system disease based on transplanting human neural stem cells and the use of small molecule drugs.
Galena Biopharma Inc. (GALE)
Galena Biopharma Inc. gained 5.98% to $2.48. The gains came on a volume of 5,852,750 shares against an average daily volume of 2,291,168 shares. Galena Biopharma Inc. has had a trading range from $7.77 to $1.66 over the last year, it has a 50-day SMA of $2.83, and a 200-day SMA of $3.37.
Galena Biopharma Inc, is a biopharmaceutical company focused on developing and commercializing, targeted treatments that address unmet medical needs to advance cancer care.
Equities.com's Health Care Small-Cap Stars - Helping You Build a Healthier Portfolio
No one can predict precisely which potential treatments will fly through their clinical trials and which will stumble along the way. At least, if someone can, they're undoubtedly spectacularly wealthy right now. But, while the science is clearly the most important factor for the success of a small-cap biotech company, it's not the only one.
Equities.com's Small-Cap Stars system uses a complicated statistical regression to determine which fundamental factors previous success stories had in common and then identifies those present health care small caps that share those traits. For health care companies, we found that a high enterprise value, a strong value line beta, and a high rate of reinvestment were among the most important qualities in predicting the potential success of a company.
All data provided by QuoteMedia and was accurate as of 4:30 pm ET.